Abstracts - faqs.org

Abstracts

Zoology and wildlife conservation

Search abstracts:
Abstracts » Zoology and wildlife conservation

Help for cytotoxic-T-cell responses is mediated by CD40 signalling

Article Abstract:

Cytotoxic T Lymphocytes (CTLs) kill target cells bearing antigens, such as cells infected with viruses. They can act alone, but often need help from CD4-positive helpers, and the help must be supplied in such a way that both helper and killer cells recognize antigen on the same target cell bearing antigens. Signalling through CD40 on cels bearing antigens is a way of replacing the requirement for helper cells, and help is mediated by this signalling.

Author: Flavell, Richard A., Heath, William R., Miller, Jacques F.A.P., Carbone, Francis R., Bennett, Sally R.M., Karamalis, Freda
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1998
Analysis, Immunological research, Immunologic research, Antigens

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Autoimmune diabetes as a consequence of locally produced interleukin-2

Article Abstract:

Autoimmune diabetes may result from the combination of autoreactive T cells and the lymphokine interleukin-2. Cell differentiation in the thymus produces these auto- or self-reactive T cells whose immunological effect was tested using transgenic mice carrying the gene for the class I molecule H-2Kb in the insulin-generating pancreatic beta-cells. Crossing these mice with transgenic mice expressing interleukin-2 in the beta-cells produced diabetes.

Author: Arnold, Bernd, Heath, William R., Allison, Janette, Hoffmann, Matthias W., Schonrich, Gunther, Hammerling, Gunter, Miller, Jacques F.A.P.
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1992
Causes of, Physiological aspects, Diabetes, Diabetes mellitus, Autoimmune diseases, Interleukin-2

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells

Article Abstract:

A new mechanism protects against autoimmunity and involves CD30. CD30-deficient islet-specific CD8-positive T cells are about 6,000 times more autoaggresive than wild-type cells. In the absence of CD30 signalling, cells activated by the CD95 dependent cross-tolerance mechanism, are able to proliferate on secondary encounter with antigen on pancreatic islets. CD30 signalling thus restricts the proliferative potential of CD8 effector T cells.

Author: Kurts, Christian, Heath, William R., Miller, Jacques F.A.P., Carbone, Francis R., Krummel, Matthew F., Koch, Karl M.
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1999
Autoimmunity

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, T cells
Similar abstracts:
  • Abstracts: The subunit story thickens. Receptor-tyrosine-kinase- and G-beta-gamma-mediated MAP kinase activation by a common signalling pathway
  • Abstracts: Nuclear receptor that identifies a novel retinoic acid response pathway. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors
  • Abstracts: The life span of the biosphere revisited. Cooling in the late Cenozoic. Susceptibility of the early Earth to irreversible glaciation caused by carbon ice clouds
  • Abstracts: Correlated responses in reproductive and carcass traits to selection for 200-day weight in Duroc swine. Correlated responses in reproductive and carcass traits to selection for 70-day weight in Landrace swine
  • Abstracts: Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.